compar
blood
rna
transcriptom
children
hospit
influenza
respiratori
syncyti
viru
rsv
bacteri
infect
healthi
control
compar
control
patient
show
increas
express
inflammatori
pathway
gene
reduc
express
adapt
immun
pathway
gene
valid
independ
cohort
signific
function
distinguish
patient
control
protein
synthesi
reduc
gene
express
reduc
express
protein
synthesi
gene
also
character
express
profil
compar
children
rsv
bacteri
infect
suggest
key
compon
pathophysiolog
respons
children
hospit
infect
increas
proport
children
admit
influenza
develop
shock
multiorgan
failur
fatal
diseas
done
recent
influenza
season
whole
blood
rna
express
profil
ideal
suit
studi
emerg
infect
allow
interrog
host
respons
publish
rna
express
studi
focus
adult
whose
respons
influenc
previou
exposur
identifi
immunopathogen
respons
children
compar
rna
express
whole
blood
prospect
recruit
children
hospit
infect
pandem
method
patient
cohort
juli
june
recruit
febril
children
year
respiratori
infect
admit
st
mari
hospit
london
whole
blood
collect
paxgen
tube
togeth
routin
clinic
sampl
patient
recruit
earli
admiss
diagnost
studi
complet
assign
diagnost
categori
result
avail
supplementari
figur
studi
approv
st
mari
research
ethic
committe
rec
written
inform
consent
obtain
viral
diagnost
undertaken
nasopharyng
aspir
use
immunofluoresc
respiratori
syncyti
viru
rsv
adenoviru
parainfluenza
viru
influenza
b
nest
polymeras
chain
reaction
pcr
rsv
coronaviru
adenoviru
parainfluenza
influenza
b
bocaviru
metapneumoviru
rhinoviru
bacteri
cultur
includ
blood
cerebrospin
fluid
csf
urin
tissu
site
pneumococc
antigen
measur
blood
urin
bacteri
dna
detect
meningococc
pneumococc
pcr
paxgen
tube
extract
use
paxgen
blood
rna
extract
kit
qiagen
quantif
qualiti
control
biotinlabel
crna
prepar
use
illumina
totalprep
rna
amplif
kit
appli
biosystem
ng
label
crna
hybrid
illumina
beadchip
microarray
scan
qualiti
control
paramet
assess
use
genom
studio
softwar
visual
inspect
microarray
imag
princip
compon
analysi
pca
two
children
rsv
bacteri
cohort
oral
intraven
steroid
prior
blood
sampl
outlier
use
pca
unsupervis
cluster
algorithm
data
shown
express
data
analyz
use
r
languag
environ
statist
comput
genespringgx
softwar
agil
describ
supplementari
method
data
deposit
ncbi
gene
express
omnibu
access
seri
access
number
http
wwwncbinlmnihgovgeoqueryacccgi
analyz
networkassoci
molecul
use
ipa
ingenu
system
wwwingenuitycom
identifi
signific
biolog
pathway
differenti
express
gene
group
differ
cohort
age
proport
white
cell
type
day
ill
onset
present
calcul
use
kruskallw
test
dunn
posttest
comparison
cohort
graphpad
prism
differ
gender
sever
ill
death
calcul
use
test
independ
supplementari
tabl
consecut
recruit
cohort
includ
patient
infect
coinfect
pathogen
rsv
infect
coinfect
bacteri
infect
supplementari
figur
thirtythre
healthi
control
children
recruit
outpati
depart
patient
demograph
clinic
data
summar
supplementari
tabl
admiss
blood
rna
express
profil
compar
patient
control
found
significantli
differenti
express
sde
transcript
p
supplementari
data
separ
patient
control
unsupervis
cluster
analysi
figur
use
support
vector
machin
svm
leaveoneout
valid
strong
class
predict
sensit
achiev
supplementari
data
patient
rsv
bacteri
infect
compar
control
identifi
sde
transcript
p
respect
supplementari
data
svm
model
rna
signatur
sensit
distinguish
rsvand
bacterialinfect
patient
respect
supplementari
data
rsv
patient
significantli
younger
control
patient
compar
rna
express
signatur
rsv
patient
subgroup
youngest
control
n
median
age
month
sde
gene
identifi
correct
p
concord
identifi
use
control
top
sde
transcript
rsv
youngest
control
repres
direct
express
data
set
biolog
pathway
distinguish
rsv
bacteri
infect
control
investig
ipa
assign
sde
transcript
known
biolog
function
pathway
biolog
function
sde
enrich
infecti
diseas
respiratori
diseas
inflammatori
respons
gene
group
supplementari
data
vs
control
data
set
function
categori
protein
synthesi
significantli
overrepres
p
furthermor
signific
canon
pathway
relat
initi
protein
translat
eukaryot
initi
factor
p
eukaryot
initi
factor
p
mammalian
target
rapamycin
mtor
p
supplementari
data
transcript
increas
abund
enrich
immun
respons
pathway
function
includ
signal
pattern
recognit
receptor
top
increas
gene
interferon
signal
antigen
present
mhc
class
hlab
transcript
reduc
abund
enrich
pathway
includ
antigen
present
mhc
class
ii
decreas
hladqa
hladpb
hladoa
tcell
signal
protein
synthesi
includ
involv
translat
elong
ribosom
transport
supplementari
data
reduc
express
sde
transcript
pathway
p
protein
synthesisrel
transcript
increas
express
includ
gene
known
inhibitori
function
protein
synthesi
includ
fold
chang
fc
respect
rel
control
valid
find
use
public
avail
adult
data
set
control
complet
segreg
patient
control
sde
transcript
data
use
cluster
supplementari
figur
use
svm
predict
model
train
vs
control
data
appli
independ
data
set
sensit
specif
diseas
control
statu
transcript
top
canon
pathway
signal
sde
valid
data
set
direct
regul
supplementari
figur
identifi
uniqu
aspect
transcript
profil
infect
compar
express
rsv
bacteri
infect
transcript
sde
rsv
n
transcript
correct
p
bacteri
infect
n
transcript
correct
p
use
unsupervis
cluster
classif
patient
distinguish
rsv
figur
bacteri
patient
figur
accuraci
vs
rsv
vs
bacteria
respect
supplementari
data
protein
synthesi
signific
function
categori
vs
rsv
vs
bacteri
infect
data
set
correct
p
respect
signific
canon
pathway
relat
protein
synthesi
pathway
p
p
mtor
p
vs
rsv
vs
bacteri
infect
respect
figur
supplementari
data
mark
differ
observ
rna
transcript
profil
patient
compar
rsv
gramposit
bacteri
infect
control
patient
show
increas
express
wellestablish
pathway
innat
antivir
immun
respons
includ
pattern
recognit
receptor
interferon
signal
myeloid
cell
activ
pathway
mani
interferoninduc
gene
antivir
role
show
increas
differenti
express
includ
p
fc
gene
implic
repress
protein
synthesi
includ
also
whose
antivir
role
may
mediat
effect
translat
vitro
murin
studi
implic
restrict
influenza
replic
find
increas
express
p
fc
support
role
infect
differ
whole
blood
rna
express
reflect
alter
proport
cell
type
andor
alter
transcript
abund
lymphocyt
proport
differ
significantli
control
fold
chang
wherea
fold
chang
top
sde
gene
use
ingenu
vari
therefor
differ
lymphocyt
proport
explain
observ
differ
although
role
lymphocyt
subset
popul
exclud
patient
show
reduc
express
adapt
immun
respons
pathway
includ
tcell
activ
nfat
b
cell
activ
mhc
class
ii
antigen
present
reduc
express
adapt
tand
bcell
pathway
may
repres
host
neg
regulatori
feedback
mechan
viralinduc
immun
subvers
analog
viral
inhibit
antigen
present
inhibit
mhc
class
ii
transactiv
signific
pathway
involv
protein
synthesi
translat
initi
mtor
within
gene
show
reduc
express
contrast
inhibitor
translat
includ
encod
pkr
upregul
pkr
phosphoryl
eukaryot
initi
factor
alpha
caus
arrest
translat
initi
suggest
protein
synthesi
patient
may
impair
repress
transcript
gene
requir
translat
apparatu
increas
transcript
translat
inhibitor
reduc
express
protein
synthesi
gene
signific
control
p
also
rsv
bacteri
infect
p
respect
figur
influenza
challeng
studi
adult
volunt
differenti
express
translat
initi
pathway
gene
identifi
symptomat
subclin
infect
support
role
alter
protein
synthesi
key
compon
host
respons
infect
increas
express
protein
synthesisinhibit
gene
reduc
express
translat
initi
gene
like
impair
protein
synthesi
influenza
viru
observ
shutoff
protein
synthesi
decreas
mrna
level
infect
cell
phenomenon
observ
peripher
blood
suggest
widespread
alter
affect
cell
distant
site
infect
hypothes
suppress
protein
synthesi
may
distinct
featur
infect
may
play
role
prolong
debil
fatigu
delay
recoveri
seen
sever
affect
patient
mani
fatal
case
acut
respiratori
distress
syndrom
requir
prolong
ventil
late
pulmonari
hemorrhag
persist
respiratori
failur
death
week
acut
ill
suppress
protein
synthesi
might
result
poor
tissu
recoveri
may
provid
explan
prolong
ill
poor
outcom
patient
pig
sepsi
impair
protein
synthesi
inhibit
mtor
pathway
cultur
influenza
viru
impair
mtor
signal
lead
autophag
cell
death
figur
top
canon
pathway
differ
control
rsv
bacteri
infect
bar
color
proport
number
sde
transcript
increas
red
decreas
green
abund
rel
compar
cohort
total
bar
length
proport
p
valu
color
block
next
pathway
code
accord
biolog
function
protein
synthesi
pathway
yellow
signific
comparison
predomin
decreas
express
patient
rel
compar
group
innat
immun
pathway
transcript
brown
increas
patient
wherea
adapt
immun
transcript
pink
reduc
rel
control
studi
requir
establish
whether
chang
observ
peripher
blood
rna
express
associ
inhibit
protein
synthesi
confirm
role
phenomenon
sever
ill
chang
express
gene
involv
protein
synthesi
observ
may
reflect
respons
viral
compon
enter
bloodstream
indirect
effect
mediat
host
inflammatori
molecul
may
advantag
viru
host
inhibit
protein
synthesi
immun
subvers
may
occur
impair
leukocyt
function
limit
product
viral
protein
may
favor
recoveri
limit
studi
includ
younger
age
rsv
cohort
ethnic
variat
popul
studi
match
group
furthermor
chang
rna
express
diseas
may
result
alter
cell
type
proport
well
upregul
downregul
gene
associ
influenza
bacteri
infect
well
known
occult
bacteri
infect
may
contribut
diseas
patient
compar
studi
rna
express
children
infect
provid
inform
host
respons
pandem
strain
find
alter
express
gene
involv
protein
synthesi
key
featur
distinguish
common
childhood
infect
offer
new
avenu
investig
immunopathogenesi
influenza
